Objective: To compare the pregnancy outcome in patients undergoing in vitro fertilization-embryo transfer (IVF-ET) cycles, using human derived foilicle-stimulating hormone (FSH) or recombinant FSH for ovarian stimulation protocols. Design: Prospective, multi-centre, randomized controlled trial. Patients: 115 infertile patients undergoing a first attempt of in vitro fertilization and embryo transfer were included in the study. The inclusion criteria were: female age <37 years and use of GnRH agonist (GnRH-a) for pituitary down-regulation. Interventions: Long Protocol-controlled ovarian stimulation with human derived FSH or recombinant FSH for IVF-ET. Main Outcome Measures: Primary end-points were implantation rate, clinical pregnancy rate and spontaneous abortion rate. Secondary end-points were total units of FSH injected, days of stimulation, peak estradiol levels at point of hCG administration, mean number of oocytes at pick-up, fertilization rate and cleavage rate. Results: No statistically significantly differences in pregnancy outcomes were found in the patients receiving hFSH in comparison to patients receiving rFSH. Conclusions: This study did not demonstrate a difference between the use of h-FSH vs r-FSH for ovarian stimulation in terms of pregnancy outcome, in good prognosis patients undergoing their first IVF-ET procedure.

OBJECTIVE: To compare the pregnancy outcome in patients undergoing in vitro fertilization-embryo transfer (IVF-ET) cycles, using human derived follicle-stimulating hormone (FSH) or recombinant FSH for ovarian stimulation protocols. DESIGN: Prospective, multi-centre, randomized controlled trial. PATIENTS: 115 infertile patients undergoing a first attempt of in vitro fertilization and embryo transfer were included in the study. The inclusion criteria were: female age < 37 years and use of GnRH agonist (GnRH-a) for pituitary downregulation. INTERVENTIONS: Long Protocol-controlled ovarian stimulation with human derived FSH or recombinant FSH for IVF-ET. MAIN OUTCOME MEASURES: Primary endpoints were implantation rate, clinical pregnancy rate and spontaneous abortion rate. Secondary end-points were total units of FSH injected, days of stimulation, peak estradiol levels at point of hCG administration, mean number of oocytes at pick-up, fertilization rate and cleavage rate. RESULTS: No statistically significantly differences in pregnancy outcomes were found in the patients receiving hFSH in comparison to patients receiving rFSH. CONCLUSIONS: This study did not demonstrate a difference between the use of h-FSH vs r-FSH for ovarian stimulation in terms of pregnancy outcome, in good prognosis patients undergoing their first IVF-ET procedure.

Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women aged < 37, undergoing ovulation induction with human FSH compared with recombinant FSH: a randomised controlled study

VICARI, Enzo Saretto;LA VIGNERA, SANDRO SALVUCCIO MARIA;
2010-01-01

Abstract

Objective: To compare the pregnancy outcome in patients undergoing in vitro fertilization-embryo transfer (IVF-ET) cycles, using human derived foilicle-stimulating hormone (FSH) or recombinant FSH for ovarian stimulation protocols. Design: Prospective, multi-centre, randomized controlled trial. Patients: 115 infertile patients undergoing a first attempt of in vitro fertilization and embryo transfer were included in the study. The inclusion criteria were: female age <37 years and use of GnRH agonist (GnRH-a) for pituitary down-regulation. Interventions: Long Protocol-controlled ovarian stimulation with human derived FSH or recombinant FSH for IVF-ET. Main Outcome Measures: Primary end-points were implantation rate, clinical pregnancy rate and spontaneous abortion rate. Secondary end-points were total units of FSH injected, days of stimulation, peak estradiol levels at point of hCG administration, mean number of oocytes at pick-up, fertilization rate and cleavage rate. Results: No statistically significantly differences in pregnancy outcomes were found in the patients receiving hFSH in comparison to patients receiving rFSH. Conclusions: This study did not demonstrate a difference between the use of h-FSH vs r-FSH for ovarian stimulation in terms of pregnancy outcome, in good prognosis patients undergoing their first IVF-ET procedure.
2010
OBJECTIVE: To compare the pregnancy outcome in patients undergoing in vitro fertilization-embryo transfer (IVF-ET) cycles, using human derived follicle-stimulating hormone (FSH) or recombinant FSH for ovarian stimulation protocols. DESIGN: Prospective, multi-centre, randomized controlled trial. PATIENTS: 115 infertile patients undergoing a first attempt of in vitro fertilization and embryo transfer were included in the study. The inclusion criteria were: female age < 37 years and use of GnRH agonist (GnRH-a) for pituitary downregulation. INTERVENTIONS: Long Protocol-controlled ovarian stimulation with human derived FSH or recombinant FSH for IVF-ET. MAIN OUTCOME MEASURES: Primary endpoints were implantation rate, clinical pregnancy rate and spontaneous abortion rate. Secondary end-points were total units of FSH injected, days of stimulation, peak estradiol levels at point of hCG administration, mean number of oocytes at pick-up, fertilization rate and cleavage rate. RESULTS: No statistically significantly differences in pregnancy outcomes were found in the patients receiving hFSH in comparison to patients receiving rFSH. CONCLUSIONS: This study did not demonstrate a difference between the use of h-FSH vs r-FSH for ovarian stimulation in terms of pregnancy outcome, in good prognosis patients undergoing their first IVF-ET procedure.
Embryo Transfer*; Follicle Stimulating Hormone, Human/pharmacology*
File in questo prodotto:
File Dimensione Formato  
Gholami et al, 2010.pdf

solo gestori archivio

Licenza: Non specificato
Dimensione 80.09 kB
Formato Adobe PDF
80.09 kB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/53788
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 8
social impact